dc.contributor.author | La Frenais, F | en_US |
dc.contributor.author | Vickerstaff, V | en_US |
dc.contributor.author | Cooper, C | en_US |
dc.contributor.author | Livingston, G | en_US |
dc.contributor.author | Stone, P | en_US |
dc.contributor.author | Sampson, EL | en_US |
dc.date.accessioned | 2023-01-12T09:44:25Z | |
dc.date.issued | 2021 | en_US |
dc.identifier.issn | 2056-4724 | en_US |
dc.identifier.other | ARTN e169 | |
dc.identifier.other | ARTN e169 | en_US |
dc.identifier.other | ARTN e169 | en_US |
dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/83722 | |
dc.relation.ispartof | BJPSYCH OPEN | en_US |
dc.rights | Attribution 3.0 United States | * |
dc.rights.uri | http://creativecommons.org/licenses/by/3.0/us/ | * |
dc.subject | Dementia | en_US |
dc.subject | antianxiety drugs | en_US |
dc.subject | antipsychotics | en_US |
dc.subject | antidepressants | en_US |
dc.subject | carers | en_US |
dc.title | Psychotropic prescribing for English care home residents with dementia compared with national guidance: findings from the MARQUE national longitudinal study | en_US |
dc.type | Article | |
dc.identifier.doi | 10.1192/bjo.2021.21 | en_US |
pubs.author-url | https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000695940400001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
pubs.issue | 5 | en_US |
pubs.notes | Not known | en_US |
pubs.publication-status | Published | en_US |
pubs.volume | 7 | en_US |
qmul.funder | The MARQUE project: Managing Agitation and Raising QUality of Life. A project to improve quality of life in people with moderate or severe dementia::Economic and Social Research Council | en_US |